Handbook of pharmaceutical science and technology studies / edited by Conor M.W. Douglas (associate professor, Department of Science, Technology and Society, York University, Canada), Susi Geiger (professor of markets, organisations and society, School of Business, University College Dublin), Tineke Kleinhout-Vliek (researcher, School of Business, University College Dublin, Ireland), Paul Martin (professor, School of Sociological Studies, Politics and International Relations, University of Sheffield, UK) and Sarah Wadmann (senior researcher, VIVE - Danish Center for Social Science Research, Denmark).

Format:

Book

Contributor:

Douglas, Conor M. W., editor.

Geiger, Susi, editor.

Kleinhout-Vliek, Tineke, editor.

Martin, Paul, editor.

Wadmann, Sarah, editor.

Edward Elgar Publishing, publisher.

Series:

Research handbooks in science and technology studies series

Language:

English

Subjects (All):

Pharmaceutical industry--Handbooks, manuals, etc.

Pharmaceutical industry.

Drugs--Research--Handbooks, manuals, etc.

Drugs.

Genre:

Electronic books.

Physical Description:

1 online resource (610 pages)

Place of Publication:

Northampton : Edward Elgar Publishing, 2026.

Summary:

"This comprehensive Handbook examines innovation in the pharmaceutical sector using ideas drawn from the interdisciplinary field of science and technology studies (STS). Leading experts present diverse social science approaches to pharmaceuticals, consolidating existing research and providing an agenda for future research in this area. International contributors critically analyse the global dynamics of knowledge production, the political economy of manufacturing, the making of markets, their regulation and governance, and the diverse ecologies of consumption for pharmaceuticals. The Handbook deconstructs the constituent parts that make up the social, political and economic power of the pharmaceutical sector while also foregrounding alternatives to the dominant mode of innovation and production. The Handbook of Pharmaceutical Science and Technology Studies is an essential resource for students and scholars in STS, economics, innovation and technology, health and social policy. It is also a valuable read for policymakers, professionals and practitioners involved in global bio-pharma innovation"-- Provided by publisher.

Contents:

Contents: Introduction to the Handbook of Pharmaceutical Science and Technology / Studies Conor Douglas, Susi Geiger, Tineke Kleinhout-Vliek, Paul Martin and Sarah Wadmann

Part I: The Development Of Pharmaceuticals

1. The production of pharmaceutical knowledge / Paul Martin

2. Myths about innovation in the pharmaceutical industry / Joel Lexchin

3. From bench to bedside and back again / Joshua R. Moon

4. Population-making in the regulatory arenas of clinical trials / Jakob Wested

5. The dynamics of "Orphanization" and the move towards precision medicine / Paul Martin, Andy Bartlett, Jin Ding, Matthew S. Hanchard and Eva Hilberg

6. How can innovation policy address "market failures" in the development of novel medicines? / Jin Ding, Michael M. Hopkins and Jorge Mestre-Ferrandiz

7. Social pharmaceutical innovation (Spin): A sensitizing concept for challenges in rare diseases / Conor M. W. Douglas, Tineke Kleinhout-Vliek, Rob Hagendijk, Wouter Boon, Claudio Cordovil Oliveira, Ellen Moors, Shir Grunebaum and Fernando Aith

Part II: Manufacturing And Production Of Pharmaceuticals

8. Introduction to Part II: The political economy of the manufacturing and production of pharmaceuticals / Conor M. W. Douglas

9. Vaccine nationalism beyond Covid-19: Prior dynamics and subsequent effects / Vesna Trifunović, Jan Hendriks and Stuart Blume

10. Peripheral vaccine promises in Latin America: Expectations, coalitions, and sovereignty / Gabriela Bortz, Mara̕ Cecilia Sanmartin and Elize Massard da Fonseca

11. A world of generics: The manufacturing and circulation of generic medicines worldwide / Etienne Nouguez

12. Manufacturing and production of advanced therapies: A case of blurred boundaries / Michael Morrison, Isabel Briz Hernandez and Conor M. W. Douglas

13. Between activism and entrepreneurship: Challenging epistemic authority through pharmaceutical peer production / Bianca Jansky, Shane O'Donnell, Henriette Langstrup and Muireann Quigley

14. Drugged ecologies: The case of pharmaceutical pollution / Gergely Mohácsi

Part III: Pharmaceutical Marketization: How Markets In / Pharma Are Made And Shaped

15. Pharmaceutical marketization: How markets in pharma are made and shaped / Susi Geiger

16. The financialization of the pharmaceutical industry: the case of Novo Nordisk's Wegovy / Prof Joan Busfield

17. "The price that we pay is not the real price of the medicine": How the pharmaceutical price architecture facilitates financial accumulation / Susi Geiger and Théo Bourgeron

18. Medical writing, the marketing playbook, and the pharmaceutical industry / Maud Bernisson, Willem Halffman and Sergio Sismondo

19. The work digital does in pharmaceutical markets / Gemma Milne and Mathias Møllebæk

20. Pharmaceuticals from and for the Global South / Jean-Paul Gaudillière and Fanny Chabrol

Part IV: Regulation And Governance Of Pharmaceuticals

21. "Regimes of pharmaceutical governance" / Tineke Kleinhout-Vliek

22. Expedited pathways in drug regulation: Evidence, uncertainty, and acceleration in biomedical innovation / Mathias Møllebæk

23. From unmet medical needs to dilemmas of access to treatment: the case of rare diseases and orphan drugs / Carlos Novas

24. The (ill)logics of patient engagement in drug development and evaluation / Olga Zvonareva and Hadewych Honné

25. Preventing, detecting, and responding to falsified and substandard medicines / Raffaella Ravinetto, Amalia Hasnida and Koen Peeters Grietens

26. Universal aspirations and contextual decisions: The Essential Medicines List and Health Technology Assessment / Tineke Kleinhout-Vliek and Susi Geiger

Part V: Use And Misuse Of Pharmaceuticals

27. Ecologies of pharmaceutical consumption / Sarah Wadmann

28. De/prescribing matters: Ecologies of prescribing and deprescribing in Science and Technology Studies / Lisa Lehner, Honja Hama, Igor Grabovac and Janina Kehr

29. Ecologies of resistance: The biosocial worlds of antibiotics / Joyce Sauann Lu and Omar Dewachi

30. Precision medicine and the reconfiguration of clinical practice and patienthood / Sarah Wadmann, Amalie Martinus Hauge, Anna Brueckner Johansen and Laura Emdal Navne

31. Beyond lay pharmacology: Fugitive, alternative, and pluralistic pharmacologies as collective practice / Magdalena Góralska, Anthony Rizk and Nayantara Sheoran Appleton

32. Pharmaceutical leakage: The porous interplay between legal and illegal opioid markets / Anne M. Lovell and Nancy D. Campbell

33. The food challenge to pharma: the unexplored potential of food drugs / Stephanie A. Nairn

Part VI: Afterword

34. Reflections: Pharmaceuticals and biotechnologies through STS lenses / Sergio Sismondo.

Notes:

Includes bibliographical references and index.

Description based on print record.

ISBN:

9781035338450 (e-book)

Access Restriction:

Restricted for use by site license.